Decision Nº M/03/042 from Competition and Consumer Protection Commission, 2004-01-22

Partiesi-STAT,Abbott Laboratories
Date22 January 2004
Decision NumberM/03/042
StatusCleared (Phase 1)
CourtCompetition and Consumer Protection Commission (Ireland)
Decision Date22 January 2004
Determination of the Competition Authority
Determination No. M/03/042 of the Competition Authority, dated 22nd January
Notification No. M/03/042 – Proposed acquisition by Abbott Laboratories of i-
STAT Corporation.
1. On 22nd December 2003 the Competition Authority, in accordance with Section
18 (1) of the Competition Act, 2002 (“the Act”) was notified, on a mandatory
basis, of a proposal whereby Abbott Laboratories (Abbott), through its wholly-
owned subsidiary Senator Acquisition Corporation, would acquire those
remaining shares of i-STAT Corporation (i-STAT) which it does not currently
The Parties
2. Abbott is a US-registered multinational corporation which is engaged in the
discovery, development, manufacture and sale of a broad and diversified line of
health care products and services. In Ireland, Abbott sells pharmaceutical
products, medical hospital products, medical diagnostics and medical nutritionals.
3. i-STAT is also a US registered corporation which develops, manufactures and
markets medical diagnostic products for blood analysis. i-STAT’s sales into
Ireland for 2002 amounted to €[ ] approximately.
4. Both parties manufacture medical diagnostic products that are used at the point of
care (POC), i.e. outside the physical facilities of clinical laboratories. Abbott
distributes i-STAT’s Irish products and has exclusive global distribution rights to
the vast majority of i-STAT’s products. Abbott estimates its share of the POC
sector in Ireland (including its distribution of i-STAT products) is [0-5]%. There
are a number of other competitors, one of which has over 60% share of the point
of care sector in Ireland. Given the competitive constraints and small market
share, the transaction does not give rise to concerns.
The Competition Authority, in accordance with Section 21(2) of the Competition Act,
2002, has determined that, in its opinion, the result of the proposed acquisition will
not be to substantially lessen competition in markets for goods and services in the
State and, accordingly, that the acquisition may be put into effect.

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT